AML Resources

expand_less

Get connected with cutting edge treatments from specialists

Clinical trials should be considered at every stage of AML treatment. Clinical trials can provide earlier access to treatments you otherwise could not receive. Remember, today's treatments are yesterday's clinical trials.

Get Started

Fall Immunity: Simple Tips for Keeping your Immune System Strong

Life with AML — September 28, 2021

We are in our first full week of Fall! As COVID-19 continues to be widespread and flu season begins, it's especially important right now to know what measures you can take to keep your immune system strong. Check out these helpful tips and a delicious immune supporting spiced carrot and pumpkin soup recipe.

Facing Acute Myeloid Leukemia: Notes from a Survivor by Steve Buechler

VOR33 Receives Fast Track Designation to Treat AML

Upcoming Events

Sep 30, 2021 / 12:00PM - 01:00PM CDT

HealthTree Radio for AML: Harnessing the Immune System in Relapsed/Refractory AML with Dr. John Reagan, Rhode Island Hospital

HealthTree Radio for AML

View details chevron_right

View all events

Upcoming HealthTree Radio for AML Show: Harnessing the Immune System in Relapsed/Refractory AML with Dr. John Reagan, Rhode Island Hospital

HealthTree Radio for AML —September 22, 2021

Join us live on September 30th at 12 PM Central to learn from Dr. Reagan, an AML specialist from Lifespan Cancer Institute at Rhode Island Hospital about what steps you can take if you have relapsed or refractory AML. He will be discussing what immunotherapy is, it’s current use in AML and his open clinical trial looking at whether the FDA approved drug gemtuzumab, followed by an infusion of blood cells called leukocytes from a donor, can stimulate the immune system to potentially fight AML.

Full Radio Show: The Advancement of Treatment Options for Older Adults with AML with Gabriel Mannis, MD, Stanford Cancer Institute

HealthTree Radio for AML —September 20, 2021

Listen to the full recording of our conversation with Dr. Gabriel Mannis, an AML expert from the Stanford Cancer Institute in California about how hypomethylating agents and venetoclax have become the new standard of care for older individuals with AML and his open clinical trial looking at what could become the first all oral therapy for newly diagnosed AML.

Why All AML Patients Need an AML Specialist

Life with AML—September 17, 2021

One of the most important things you can do as a patient with AML is to have an AML specialist on your team. Jenny Alhstrom, blood cancer survivor, explains why.

The HealthTree® Foundation Unveils the First and Only Clinical Trial Finder Tool Designed Specifically for Acute Myeloid Leukemia (AML) Patients

HealthTree for AML Newsroom—September 17, 2021

The HealthTree® Foundation, a patient-driven, 501(c)(3) non-profit organization that empowers patients at each step of their disease journey, announces the launch of its clinical trial finder for acute myeloid leukemia (AML). Using the tool, AML patients can filter their clinical trial search - personalizing, simplifying, and accelerating the enrollment process.

A Review of the Role of Vitamin D in AML

AML News—September 15, 2021

While vitamin D deficiency is widespread among many countries including the United States, your vitamin D level may be even more important if you have AML. There are several studies that have shown vitamin D deficiency is more common among people with acute leukemias, and that lower vitamin D levels in blood cancers may be associated with poorer outcomes and responses to treatment.